Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Annals of the Rheumatic Diseases · 2026-06 · 85 (6) · 1055-1072
DOI: 10.1016/j.ard.2026.02.024 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of the Rheumatic Diseases, 2026-06. Verfasst von Faidra Laskou und 17 weiteren Autor:innen. Beteiligte Einrichtung: MRC Lifecourse Epidemiology Centre Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: f.laskou@s…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Biological Products, Synthetic Drugs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EULAR.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRC Lifecourse Epidemiology Centre Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: f.laskou@soton.ac.uk.
- Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
- NIHR Southampton Clinical Research Facility, University Hospital Southampton, Southampton, UK.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- School of Public Health, Oregon Health & Science University, Portland, OR, USA.
- Department of Rheumatology and Applied Immunology/Clinical Immunology, Saitama Medical University, Moroyama-machi, Iruma, Saitama, Japan.
Förderung
- EULAR
Zitieren
APA
Laskou, F., Konzett, V., Smolen, J. S., Edwards, C. J., Aletaha, D., van der Heijde, D., Winthrop, K. L., Takeuchi, T., Caporali, R., Verschueren, P., Pope, J. E., Hyrich, K., de Souza, S., Stamm, T. A., Primdahl, J., Schoones, J. W., Landewé, R. B., & Kerschbaumer, A. (2026). Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases, 85(6), 1055-1072. https://doi.org/10.1016/j.ard.2026.02.024
Vancouver
Laskou F, Konzett V, Smolen JS, Edwards CJ, Aletaha D, van der Heijde D, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2026;85(6):1055-1072. doi:10.1016/j.ard.2026.02.024
BibTeX
@article{Laskou2026,
author = {Laskou, Faidra and Konzett, Victoria and Smolen, Josef S and Edwards, Christopher J and Aletaha, Daniel and van der Heijde, Désirée and Winthrop, Kevin L and Takeuchi, Tsutomu and Caporali, Roberto and Verschueren, Patrick and Pope, Janet E and Hyrich, Kimme and de Souza, Savia and Stamm, Tanja A and Primdahl, Jette and Schoones, Jan W and Landewé, Robert Bm and Kerschbaumer, Andreas},
title = {Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {6},
pages = {1055--1072},
doi = {10.1016/j.ard.2026.02.024}
}
EUVIMED